Koss-Olinger Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-370	Closed	-$235K	–	326
2025 Q1	$235K	Buy	+370	New	+$254K	0.02%	278
2024 Q4	–	Sell	-353	Closed	-$371K	–	267
2024 Q3	$371K	Buy	353 +24	+7%	+$26.7K	0.03%	198
2024 Q2	$346K	Buy	+329	New	+$319K	0.03%	193
2024 Q1	–	Sell	-320	Closed	-$281K	–	238
2023 Q4	$281K	Hold	320	–	–	0.03%	244
2023 Q3	$263K	Hold	320	–	–	0.04%	215
2023 Q2	$230K	Hold	320	–	–	0.03%	229
2023 Q1	$263K	Buy	320 +26	+9%	+$19.6K	0.03%	192
2022 Q4	$212K	Sell	294 -125	-30%	-$92.2K	0.03%	202
2022 Q3	$289K	Buy	419 +56	+15%	+$35.2K	0.05%	158
2022 Q2	$215K	Buy	363 +13	+4%	+$8.45K	0.04%	159
2022 Q1	$244K	Sell	350 -135	-28%	-$85.4K	0.04%	162
2021 Q4	$306K	Buy	485 +18	+4%	+$11.1K	0.05%	154
2021 Q3	$283K	Buy	+467	New	+$290K	0.05%	181